Skip to main content
Equibles

Rubric Capital Management LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1687509 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$68,412,296
+$4,172,296 QoQ
Shares Held
8,540,861
+6.8% QoQ
Ownership
8.59%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#2
of 208 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. SPRY ranks #9 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARQT
Arcutis Biotherapeutics, Inc.
 8,271,577 $216,880,748
2 ROIV
Roivant Sciences Ltd.
 6,000,000 $212,340,000
3 ZYME
Zymeworks Inc.
 7,000,000 $182,980,000
4 NRIX
Nurix Therapeutics, Inc.
 7,227,778 $175,345,894
5 MGTX
MeiraGTx Holdings plc
 9,100,000 $122,941,000
6 ARDX
Ardelyx, Inc.
 16,202,700 $82,633,770
7 ADMA
Adma Biologics, Inc.
 9,339,414 $78,170,895
8 MNKD
Mannkind Corp
 18,000,000 $76,680,000

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,412,296 8,540,861
2026-03-31 $64,240,000 8,000,000
2025-12-31 $72,230,000 6,200,000
2025-09-30 $45,225,000 4,500,000
2025-06-30 $22,595,621 1,294,878
2025-03-31 $12,946,090 1,029,101
2024-06-30 $5,439,617 639,203
2024-03-31 $6,532,654 639,203
2023-12-31 $3,502,832 639,203
2023-09-30 $2,416,187 639,203
2023-06-30 $18,754,660 2,799,203
2023-03-31 $22,659,435 3,480,712
2022-12-31 $25,509,510 2,990,564
2022-09-30 $14,230,497 2,695,170
2022-06-30 $4,182,560 986,453